Increased Sialylation of Anti-Thomsen-Friedenreich Antigen (CD176) Antibodies in Patients with Gastric Cancer: A Diagnostic and Prognostic Potential

Figure 7

The probability of survival of gastric cancer patients in subgroups stratified by TF-specific antibody SNA reactivity and TF IgM level. The stratification of cancer patients into four subgroups was performed as shown in Figure 5 by using the median of SNA binding and anti-TF IgM level value as cut-off: (1) patients with an SNA binding value that is equal to or more than median and anti-TF IgM level that is equal to or more than median; that is, SNA ≥ IgM ≥, (2) SNA < IgM ≥, (3) SNA ≥ IgM<, and (4) SNA < IgM < subgroup.